Charles River Associates’ (CRA) Global Life Sciences Practice Launches Data Analytics Platform

Rhea-AI Summary

Charles River Associates (CRAI) has launched its innovative Healthcare Claims Analytics Platform (HCAP) at the World Orphan Drug Congress USA 2022 in Boston. This new modular analytics tool aims to enhance decision-making for clients by analyzing patient, healthcare practitioner, and healthcare organization data. Developed over 18 months by CRA's Life Sciences Practice, HCAP supports advanced analytics, clinical trial strategies, and market insights. CRA's commitment to innovation is evident in this launch, designed to meet the needs of biotech and pharmaceutical firms globally.

Positive

• Launch of HCAP provides advanced data-visualization and analytics capabilities.
• Supports clients in informed decision-making across therapeutic and geographic markets.
• HCAP's clinical trial module aids in recruitment and resource prioritization.

Negative

• Forward-looking statements may indicate uncertain future performance and potential client loss.

CRA’s Healthcare Claims Analytics Platform (HCAP) Formally Announced at World Orphan Drug Congress USA 2022

BOSTON--(BUSINESS WIRE)-- Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced the launch of the Company’s new data analytics suite, the Healthcare Claims Analytics Platform (HCAP), at the World Orphan Drug Congress USA 2022 in Boston. Developed by CRA’s Life Sciences Practice, HCAP is a modular, dynamic, data-visualization tool that provides streamlined analysis of patient, Health Care Practitioner (HCP), and Health Care Organization (HCO) data to support insight generation and decision-making.

“The development and launch of HCAP is an exciting achievement for CRA and reflects our commitment to generating value through innovation,” said CRA’s President and Chief Executive Officer Paul Maleh. “For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements. I’d like to congratulate the HCAP team, led by Eddie Li, Travis Ruch, Birnur Ozbas-Erdem and Jing Li, for their dedicated work on this project. I look forward to further advancements from our Analytics team.”

“HCAP delivers the power of machine learning and patient analytics to inform market understanding and support intelligent decision-making,” said CRA’s Life Sciences Practice Leader and Vice President, Gregory K. Bell. “Our Analytics team spent a year and a half developing the interface, which is compatible with a variety of data sources and can be customized for client needs. With HCAP, clients can develop insights that inform strategic decisions and key business operations across therapeutic and geographic markets.”

HCAP can support clients in visualizing advanced analytics by providing intelligence on patients, physicians, hospitals, and the broader healthcare market. HCAP also offers a clinical trial module to bolster recruitment and resource-prioritization strategies through the identification of key providers and centers in patient treatment and care.

About CRA's Life Sciences Practice
The CRA Life Sciences Practice works with leading biotech, medical device, and pharmaceutical companies; law firms; regulatory agencies; and national and international industry associations. We provide the analytical expertise and industry experience needed to address our clients’ toughest issues. We have a reputation for rigorous and innovative analysis, careful attention to detail, and the ability to work effectively as part of a wider team of advisers.

About Charles River Associates (CRA)
Charles River Associates® is a leading global consulting firm specializing in economic, financial, and management consulting services. CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings, and guides corporations through critical business strategy and performance-related issues. Since 1965, clients have engaged CRA for its unique combination of functional expertise and industry knowledge, and for its objective solutions to complex problems. Headquartered in Boston, CRA has offices throughout the world. Detailed information about Charles River Associates, a registered trade name of CRA International, Inc., is available at www.crai.com. Follow us on LinkedIn, Twitter, and Facebook.

SAFE HARBOR STATEMENT
Statements in this press release concerning the launch of the Healthcare Claims Analytics Platform (HCAP), its capabilities, and any future business it may generate for CRA are “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based upon management’s current expectations and are subject to a number of factors and uncertainties. Information contained in these forward-looking statements is inherently uncertain, and actual performance and results may differ materially due to many important factors. Such factors that could cause actual performance or results to differ materially from any forward-looking statements made by CRA include, among others, the potential loss of clients; the demand environment; global economic conditions; foreign exchange rate fluctuations; and intense competition, as well as other potential factors that could affect our financial results are included in our periodic filings with the Securities and Exchange Commission, including those under the heading “Risk Factors.” We cannot guarantee any future results, levels of activity, performance, or achievement. We undertake no obligation to update any forward-looking statements after the date of this press release, and we do not intend to do so.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220712005726/en/

Media Relations

CRA International

media@crai.com

617-425-6453

Nicholas Manganaro

Sharon Merrill Associates, Inc.

crai@investorelations.com

617-542-5300

Source: Charles River Associates

FAQ

What is the Healthcare Claims Analytics Platform (HCAP) by CRA?

HCAP is a modular data analytics tool launched by Charles River Associates for analyzing healthcare data to support decision-making.

When was HCAP launched?

HCAP was launched at the World Orphan Drug Congress USA 2022.

What capabilities does HCAP offer?

HCAP offers machine learning analytics for patient data, clinical trial support, and customizable insights.

What markets does HCAP target?

HCAP is designed for the biotech, medical device, and pharmaceutical markets.

What are the potential risks associated with HCAP according to CRA?

Potential risks include client loss, demand fluctuations, and intense competition.